Joseph Sleiman, MD, FACP
@JosephHabibi_MD
🏳️🌈🇱🇧 IBD fellow @ClevelandClinic, Alumni @PittGILiverNutr #SoMe Editor @ACG_EBGI ➡️ @AGA_CGH🧵 #CGH4ALL #IBDAlgorithm @MondayNightIBD👨⚕️ tweets my own
Happy to bring back my USA education & GI experience in a full circle 📣 Virtual Talk w/ Real-world advice: -Residency & fellowship matching -Research & leadership as an IMG -Career-building in IM & GI 🎯My journey from medical school in Lebanon to training & securing a…
Let’s all show our support to @CMacaronMD!! 👏🏻 @JPAchkarMD @Ari_G_MD @MichelleKimMD @MRegueiroMD @burkegastrodoc @CarolRouphaelMD @Chatterjee_MD @SuhaAbushamma @RobertoSimonsMD @amitbhattMD @SiddikiGI @HishamWehbeMD @mattie_md @akashkhurana_ @AbdulAhmedMD
🌄Our Rising Disruptor noms are just getting started. @ClevelandClinic and @GoHealio had a hard time narrowing down the field. Who will win the title? @CMacaronMD @DrSudhaPandit @renumathyd @IrisWangMD @egsheu Prashant Singh @UMichInterEndo Vote here: bit.ly/4fdJXKo
🚨 Attention 1️⃣st year GI fellows 🚨 Enjoying your first few weeks of fellowship? Still struggling to find your feet? 😬 🌟 Check out our GI Fellow Handbook 📖 💡 A nifty guide for tips, tricks, and advice for those formulative early months ✅ ✍️ BY 1st years ✍️ FOR 1st years
Many surprises in this @AGA_CGH meta analysis JAKi no better than placebo for ileal disease Stronger effect of Vedo for ileal than for colonic disease A progress towards positioning in #IBD Will patients with refractory ileocolonic disease benefit from a JAKi+Vedo combo?
#CGH4ALL📣 💥 Check out the💡new data on #IBS care disparities in @AGA_CGH🔥! 🔗 doi.org/10.1016/j.cgh.… Reported by @ifrahfatima @AndreaShin_GI @LinChangMD @ArpanaChurch @GregSayuk @IBS_Maastricht @MelchiorChloe @AndrewOngML @InclusiveIBS @BrennanSpiegel @mgrover_gi
#CGH4ALL 📣 💊 GLP-1 agonists in IBD? 👀 Safe, effective for weight loss 🔥 May help reduce inflammation (↓ CRP) 🌟 Especially promising in ulcerative colitis! Read the complete study here @AGA_CGH 🔗 doi.org/10.1016/j.cgh.… Reported by @arianapg @phillyIBDdoc @blakely_md…
#CGH4ALL @AGA_CGH 📣 With rising prevalence of chronic liver disease in young adults, there is an increase in relevance for data on safety and outcomes for infertility treatment! Reported by @Ansari_Zaid7 🔗 cghjournal.org/article/S1542-… @Meera_Garriga @MonikaSarkar @whcop…
#CGH4ALL📣 💥 Injectable Naltrexone has an overall better GI and liver safety profile compared to other FDA-approved drugs for Alcohol use disorder (AUD) @Wei_Zhang_Liver @doc_sooyoung @AGA_CGH🔥!🔗 doi.org/10.1016/j.cgh.… Reported by @ifrahfatima @BlaneyMD @NoureddinMD…
😄 2 out of 2 abstracts accepted, excited to present at #ACG2025 in Phoenix🌵! 🧠 P1110: Global HCP Perspectives on AI in IBD Care 🤝 P1925: Trainee Insights on #GITwitter & Career Development (ACG-EBGI-led) @JosephHabibi_MD @Bealoquebea @MItaniMD @SophiaDar1 @AshkanRA
Alright, #ACGFamily, it's time! 🚨 💻 Check your emails 🔗 Register now for #ACG2025 🌵 📸 Post abstracts you'll be presenting 📍Tag us @AmCollegeGastro and build your network 🥊Let's go! @AmyOxentenkoMD @umfoodoc
3rd @Y_ECCO_IBD Mentorship Forum, Vienna, Austria ✅Becoming an IKL (Innovation knowledge Leader), not just a KOL ☑️Succeeding at living as a physician & scientist ✅Multi-center trial design simulation + shark tank ☑️New & old friends @ibdseb @bverstockt @virgisolitano…
#CGH4ALL 📣 🧐How risky are subcentimeter liver nodules? 📊This systematic review shows up to 20% may develop HCC, but newer studies show lower risk 🎯Better risk stratification models are needed! 🖇️ doi.org/10.1016/j.cgh.… Reported by @arianapg @KarimDahanMD @darinedaher…
🗞️Check out the #REACHIBD summer newsletter for #GI fellows and early-career #IBD pros. Insightful patient stories, ☀️ #stoma tips to share, and more! @fudmanMD @tqaziMD @GutlessGlamour @esna_mary @IBDProNews @CrohnsColitisFn crohnscolitisfoundation.aflip.in/REACHIBDsummer…
🔵 Interested in Global IBD and future scenarios? Very happy to see our review published in @UEGJournal with IBD Master and good friend @ibdseb 👍
#CGH4ALL @AGA_CGH 📣 As we look for more targets in therapy of UC, this study reports on an IL-22 Agonist that did not have efficacy when compared to placebo or Vedo! 🔗 cghjournal.org/article/S1542-… Reported by @Ansari_Zaid7 @ibd_pal @EdBarnesMD @IBDGastroDocSg @Bealoquebea…
#CGH4ALL @AGA_CGH 📣 It is inevitable that you will see patients with disorders of gut-brain interaction– read this expert review to learn about evaluation for coexisting hypermobility, orthostasis and mast cell disorders! Reported by @Ansari_Zaid7 🔗 cghjournal.org/article/S1542-……
#CGH4ALL📣 💥 🚨 New international consensus on ASUC trial design! 📖 #IBD #ASUC #UlcerativeColitis #ClinicalTrials #Gastroenterology @AGA_CGH🔥!🔗 doi.org/10.1016/j.cgh.… Reported by @ifrahfatima…
#CGH4ALL 📣 @AGA_CGH 💊 Do antibiotics fuel early-onset colon cancer? 🧪 In this large US study, the answer is: not likely 📉 No clear link found between adult antibiotic use and EOCRC risk 🖇️ doi.org/10.1016/j.cgh.… Reported by @arianapg @JeffLeeMD @aileenbui @kpnorcalGI…
🚨 Application deadline extended to July 18! The ASGE AI Scholars Program offers a fully funded year of AI training for aspiring GI leaders. Get personalized mentorship, attend exclusive workshops, and contribute to a dynamic team project. Apply now: tinyurl.com/AIScholars2025
📢 CGH is thrilled to welcome its new Editorial Fellows @slchung_md and @SedkiMD. 📰 To see the editorial fellows selected for our sister journals, read more: ow.ly/W3o950WjT3j @JosephHabibi_MD @YaleMed @univmiami
Endoscopic Sedation Type During FLIP Panometry Does Not Significantly Impact FLIP Motility Classification Relative to Manometry ➡️ ow.ly/vZZH50WhOKN